“Seniors with diabetes are now paying $35 [a month] for insulin instead of $400.”
The promise
Under Biden’s health and drug reform agenda, the Inflation Reduction Act introduced a cap on monthly insulin costs for Medicare beneficiaries (at $35) and also placed a hard limit on out-of-pocket drug expenditures (such as $2,000 annual cap). These moves were major components of his promise to make essential medicines more affordable. Supporters hailed them as landmark consumer protections. Some critics say the full benefits require fuller implementation, but these key reforms have been legally enacted and are active. Thus the promise is widely regarded as kept.
